Professor Anthony Gill
Professor Anthony Gill graduated in medicine from the University of Sydney in 1997. He completed his specialty training in surgical pathology (FRCPA) in 2005 and since then has divided his time between diagnostic pathology as a senior staff specialist at Royal North Shore Hospital and medical research, both at the Garvan Institute of Medical Research of Medical Research and the University of Sydney. His research has concentrated on translating advances made in the understanding of cancer at the basic science or molecular level into diagnostic tests which can be applied in the routine surgical pathology laboratory on patient biopsy specimens. He has authored more than 250 peer reviewed publications and was a member of the World Health Organisation (WHO) consensus committee which recently finalised the newly released WHO 2017 classification of endocrine neoplasia. He is a Professor of Surgical Pathology at the University of Sydney and current chairman of the Australian Pancreatic Cancer Genome Initiative.
- 2011Benjamin Castleman award
- 2011John Loewenthal Medal and a higher doctorate by publication (MD) from the University of Sydney
- 2013NSW Premier’s Award for Excellence in Translational Cancer Research in
- 2014Sir Zelman Cowen Universities Prize for discovery in Medical Research
- 2017Ramzi Cotran you Investigator Award by the United States and Canadian Academy of Pathology (USCAP)
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.
Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions.